Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden
================================================================================================================================================================================

* Michael Schenker
* Mauricio Burotto
* Martin Richardet
* Tudor-Eliade Ciuleanu
* Anthony Gonçalves
* Neeltje Steeghs
* Patrick Schoffski
* Paolo A Ascierto
* Michele Maio
* Iwona Lugowska
* Lorena Lupinacci
* Alexandra Leary
* Jean-Pierre Delord
* Julieta Grasselli
* David S P Tan
* Jennifer Friedmann
* Jacqueline Vuky
* Marina Tschaika
* Somasekhar Konduru
* Sai Vikram Vemula
* Ruta Slepetis
* Georgia Kollia
* Misena Pacius
* Quyen Duong
* Ning Huang
* Parul Doshi
* Jonathan Baden
* Massimo Di Nicola